US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Biotechnology Company Reports Market Research Reports & Industry Analysis

RSS Feeds

Biotechnology Company Reports Industry Research & Market Reports

< prev 1    3  4  5  6  7  8  9  10  
Global Joint Venture Partnerhsips in Pharma, Biotech and Diagnostics
10/1/2014 | published by: Current Partnering
... by the worlds leading healthcare companies. This new 1st edition, includes: Trends in joint venture deals Joint venture agreement structure Joint venture contract documents Top joint venture deals by value Most active joint venture dealmakers ...  |  read more...
USD 1,995
Top 50 Big Biotech Partnering and M&A Deal Trends
10/1/2014 | published by: Current Partnering
... the worlds leading fifty big biotech companies. Top 50 Big Biotech Partnering and M&A Deal Trends provides the user with the following key benefits: Detailed partnering activity profiles for each of the top 50 big ...  |  read more...
USD 2,195
Novartis AG - Product Pipeline Review - 2014
9/30/2014 | published by: Global Markets Direct
... provides comprehensive information on the current therapeutic developmental pipeline of Novartis AG’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. ...  |  read more...
USD 1,500
Bioscience (UK) - Industry Report
10/7/2014 | published by: Plimsoll Publishing Ltd.
... – analysing the 240 largest Bioscience (UK) companies. The Bioscience (UK) report contains the most-up-to-date financial data and Plimsoll applies these figures to create their unique and authoritative analysis. Indeed, the first section thoroughly scrutinises ...  |  read more...
USD 560
Biotechnology in the United Kingdom
10/2/2014 | published by: Plimsoll Publishing Ltd.
... activities such as dna, contract pharmaceutical drug development services, biotechnology, microbiology, hygiene and includes a wealth of information on the financial trends over the past four years. latest Biotechnology analysis is perfect for investors to: ...  |  read more...
USD 525
Instrumentation Engineers (UK) - Industry Report
10/7/2014 | published by: Plimsoll Publishing Ltd.
... graphical analysis – analysing the 80 largest Instrumentation Engineers (UK) companies. The Instrumentation Engineers (UK) report contains the most-up-to-date financial data and Plimsoll applies these figures to create their unique and authoritative analysis. Indeed, the ...  |  read more...
USD 560
Biotech Financial Reports October 2014
10/1/2014 | published by: Worldwide Videotex
BIOTECH FINANCIAL REPORTS provides the latest financial information and news on biotech and pharmaceutical companies. This includes quarterly and annual reports plus merger and acquisition news, and stock dividend announcements.  |  read more...
USD 25
Worldwide Biotech October 2014
10/1/2014 | published by: Worldwide Videotex
... an international industry, reporting on the deals between U.S. biotechnology companies and international pharmaceutical corporations. Monitors the emerging European Community marketplace and the growing Japanese interest and deals in the U.S. biotechnology and pharmaceuticals industry.  |  read more...
USD 25
Five Prime Therapeutics, Inc. - Product Pipeline Review - 2014
9/22/2014 | published by: Global Markets Direct
... research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Five Prime Therapeutics, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action ...  |  read more...
USD 1,500
BioMarker Strategies, LLC - Product Pipeline Analysis, 2014 Update
9/18/2014 | published by: GlobalData
... next generation predictive tests - known as PathMap profiles - to guide targeted drug therapy selection for individual cancer patients. BioMarker Strategies is developing a pipeline of unique ex vivo biomarker tests to inform targeted ...  |  read more...
USD 750
Biosceptre International Limited - Product Pipeline Analysis, 2014 Update
9/18/2014 | published by: GlobalData
... cancer. Biosceptre’s diagnostic products are used for the detection of various cancer tissues, and treatment of various cancers in humans and other mammals. The company has a series of product development programmes including polyclonal antibody, ...  |  read more...
USD 750
Cavadis B.V. - Product Pipeline Analysis, 2014 Update
9/18/2014 | published by: GlobalData
... of development. Cavadis’s product CAV?RISK ASSAYS is used for cardiovascular indications, and CAV?RISK C?D is developed for coronary artery disease (CAD). The company’s products are developed for cardiovascular indications, including stroke, myocardial infarction (MI), and ...  |  read more...
USD 750
Ceres Nanosciences, Inc. - Product Pipeline Analysis, 2014 Update
9/18/2014 | published by: GlobalData
... development and Nanotrap lyme antigen test. Ceres Nanosciences’ Nanotrap particles are a protein enrichment toolset that can be integrated seamlessly into any existing downstream measurement and analysis process. The company’s Nanotrap High sensitivity lyme antigen ...  |  read more...
USD 750
Nuclea Biotechnologies Inc. - Product Pipeline Analysis, 2014 Update
9/18/2014 | published by: GlobalData
... colon, stomach, leukemia, lung and prostate. Nuclea utilizes its proprietary DecisionDx platform in the development of in vitro companion diagnostics for use in therapeutic and medical imaging applications. It conducts research on novel molecular oncology ...  |  read more...
USD 750
OncoSec Medical Inc. (ONCS) - Product Pipeline Analysis, 2014 Update
9/18/2014 | published by: GlobalData
... two kinds of tests to eradicate various kinds of cancers such as ImmunoPulse and NeoPulse. OncoSec’S ImmunoPulse is used to treat metastatic cancers. The company’s NeoPulse is used to treat primary and recurrent cancers that ...  |  read more...
USD 750
Panacea Biotec Limited (PANACEABIO) - Financial and Strategic SWOT Analysis Review
9/15/2014 | published by: GlobalData
... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ...  |  read more...
USD 125
Celera Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
9/22/2014 | published by: MarketLine
... Project Description: MarketLines' Celera Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions ...  |  read more...
USD 350
WaferGen Bio-systems, Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
9/22/2014 | published by: MarketLine
... Project Description: MarketLines' WaferGen Bio-systems, Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership ...  |  read more...
USD 350
Genetic Technologies Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
9/22/2014 | published by: MarketLine
... Project Description: MarketLines' Genetic Technologies Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership ...  |  read more...
USD 350
Lonza Group, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
9/22/2014 | published by: MarketLine
... Project Description: MarketLines' Lonza Group, Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership ...  |  read more...
USD 350
International Stem Cell Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
9/22/2014 | published by: MarketLine
... Project Description: MarketLines' International Stem Cell Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and ...  |  read more...
USD 350
Oxygen Biotherapeutics, Inc. (formerly Synthetic Blood International, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
9/22/2014 | published by: MarketLine
... Project Description: MarketLines' Oxygen Biotherapeutics, Inc. (formerly Synthetic Blood International, Inc.) Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture ...  |  read more...
USD 350
Bayer MaterialScience AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
9/22/2014 | published by: MarketLine
... Project Description: MarketLines' Bayer MaterialScience AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership ...  |  read more...
USD 350
Genentech, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
9/22/2014 | published by: MarketLine
... Project Description: MarketLines' Genentech, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions ...  |  read more...
USD 350
Generex Biotechnology Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
9/22/2014 | published by: MarketLine
... Project Description: MarketLines' Generex Biotechnology Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership ...  |  read more...
USD 350
< prev 1    3  4  5  6  7  8  9  10